599
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Cell cooperation and role of the P2X7 receptor in pulmonary inflammation induced by nanoparticles

, , , , , , & show all
Pages 1302-1314 | Received 15 May 2012, Accepted 24 Sep 2012, Published online: 24 Oct 2012

References

  • Alfaro-Moreno E, Nawrot TS, Vanaudenaerde BM, Hoylaerts MF, Vanoirbeek JA, Nemery B, et al. 2008. Co-cultures of multiple cell types mimic pulmonary cell communication in response to urban PM10. Eur Respir J 32(5):1184–1194.
  • Allouni ZE, Cimpan MR, Hol PJ, Skodvin T, Gjerdet NR. 2009. Agglomeration and sedimentation of TiO2 nanoparticles in cell culture medium. Colloids Surf B Biointerfaces 68(1):83–87.
  • Arora S, Rajwade JM, Paknikar KM. 2012. Nanotoxicology and in vitro studies: the need of the hour. Toxicol Appl Pharmacol 258(2): 151–165.
  • Auwerx J. 1991. The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Experientia 47(1):22–31.
  • Barth K, Weinhold K, Guenther A, Young MT, Schnittler H, Kasper M. 2007. Caveolin-1 influences P2X7 receptor expression and localization in mouse lung alveolar epithelial cells. Febs J 274(12):3021–3033.
  • Baudouin C, Riancho L, Warnet JM, Brignole F. 2007. In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost. Investig Ophthalmol Vis Sci 48(9):4123–4128.
  • Beck-Schimmer B, Schwendener R, Pasch T, Reyes L, Booy C, Schimmer RC. 2005. Alveolar macrophages regulate neutrophil recruitment in endotoxin-induced lung injury. Respir Res 6:61.
  • Budagian V, Bulanova E, Brovko L, Orinska Z, Fayad R, Paus R, et al. 2003. Signaling through P2X7 receptor in human T cells involves p56lck, MAP kinases, and transcription factors AP-1 and NF-kappa B. J Biol Chem 278(3):1549–1560.
  • Card JW, Zeldin DC, Bonner JC, Nestmann ER. 2008. Pulmonary applications and toxicity of engineered nanoparticles. Am J Physiol Lung Cell Mol Physiol 295(3):L400–L411.
  • Chang JS, Chang KL, Hwang DF, Kong ZL. 2007. In vitro cytotoxicitiy of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line. Environ Sci Technol 41(6): 2064–2068.
  • Cho WS, Choi M, Han BS, Cho M, Oh J, Park K, et al. 2007. Inflammatory mediators induced by intratracheal instillation of ultrafine amorphous silica particles. Toxicol Lett 175(1-3):24–33.
  • Crapo JD, Barry BE, Gehr P, Bachofen M, Weibel ER. 1982. Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis 126(2):332–337.
  • Demento SL, Eisenbarth SC, Foellmer HG, Platt C, Caplan MJ, Mark Saltzman W, et al. 2009. Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy. Vaccine 27(23):3013–3021.
  • Dinarello CA. 2009. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519–550.
  • Donaldson K, Tran CL. 2002. Inflammation caused by particles and fibers. Inhal Toxicol 14(1):5–27.
  • Donnelly-Roberts DL, Namovic MT, Faltynek CR, Jarvis MF. 2004. Mitogen-activated protein kinase and caspase signaling pathways are required for P2X7 receptor (P2X7R)-induced pore formation in human THP-1 cells. J Pharmacol Exp Ther 308(3):1053–1061.
  • Dutot M, Liang H, Pauloin T, Brignole-Baudouin F, Baudouin C, Warnet JM, et al. 2008. Effects of toxic cellular stresses and divalent cations on the human P2X7 cell death receptor. Mol Vis 14:889–897.
  • Elgrabli D, Abella-Gallart S, Aguerre-Chariol O, Robidel F, Rogerieux F, Boczkowski J, et al. 2007. Effect of BSA on carbon nanotube dispersion for in vivo and in vitro studies. Nanotoxicology 1(4):266–278.
  • Ferrari D, Pizzirani C, Adinolfi E, Lemoli RM, Curti A, Idzko M, et al. 2006. The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 176(7):3877–3883.
  • Gazdar AF, Linnoila RI, Kurita Y, Oie HK, Mulshine JL, Clark JC, et al. 1990. Peripheral airway cell differentiation in human lung cancer cell lines. Cancer Res 50(17):5481–5487.
  • Geiser M, Rothen-Rutishauser B, Kapp N, Schurch S, Kreyling W, Schulz H, et al. 2005. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 113(11):1555–1560.
  • Guth AM, Janssen WJ, Bosio CM, Crouch EC, Henson PM, Dow SW. 2009. Lung environment determines unique phenotype of alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 296(6):L936–L946.
  • Hjort MR, Brenyo AJ, Finkelstein JN, Frampton MW, LoMonaco MB, Stewart JC, et al. 2003. Alveolar epithelial cell-macrophage interactions affect oxygen-stimulated interleukin-8 release. Inflammation 27(3):137–145.
  • Humphreys BD, Virginio C, Surprenant A, Rice J, Dubyak GR. 1998. Isoquinolines as antagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat receptor homologues. Mol Pharmacol 54(1):22–32.
  • ISO. 2008. Nanotechnologies – Terminology and definitions for nano-objects – Nanoparticle, nanofibre and nanoplate. ISO/TS 27687:2008.
  • Jiang LH, Mackenzie AB, North RA, Surprenant A. 2000. Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors. Mol Pharmacol 58(1):82–88.
  • Kamp DW, Dunn MM, Sbalchiero JS, Knap AM, Weitzman SA. 1994. Contrasting effects of alveolar macrophages and neutrophils on asbestos-induced pulmonary epithelial cell injury. Am J Physiol 266(1 Pt 1):L84–L91.
  • Kasper J, Hermanns MI, Bantz C, Maskos M, Stauber R, Pohl C, et al. 2011. Inflammatory and cytotoxic responses of an alveolar-capillary coculture model to silica nanoparticles: comparison with conventional monocultures. Part Fibre Toxicol 8(1):6.
  • Klein SG, Hennen J, Serchi T, Blomeke B, Gutleb AC. 2011. Potential of coculture in vitro models to study inflammatory and sensitizing effects of particles on the lung. Toxicol In Vitro.
  • Kolliputi N, Galam L, Parthasarathy PT, Tipparaju SM, Lockey R. 2011. NALP-3 inflammasome silencing attenuates ceramide induced transepithelial permeability. J Cell Physiol 25(8): 1516–1534.
  • Lanone S, Rogerieux F, Geys J, Dupont A, Maillot-Marechal E, Boczkowski J, et al. 2009. Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines. Part Fibre Toxicol 6:14.
  • Martinon F, Mayor A, Tschopp J. 2009. The inflammasomes: guardians of the body. Annu Rev Immunol 27:229–265.
  • Murphy FA, Schinwald A, Poland CA, Donaldson K. 2012. The mechanism of pleural inflammation by long carbon nanotubes: interaction of long fibres with macrophages stimulates them to amplify pro-inflammatory responses in mesothelial cells. Part Fibre Toxicol 9:8.
  • Naitoh T, Kitahara M, Tsuruzoe N. 2001. Tumor necrosis factor-alpha is induced through phorbol ester–and glycated human albumin-dependent pathway in THP-1 cells. Cell Signal 13(5):331–334.
  • Napierska D, Thomassen LC, Vanaudenaerde B, Luyts K, Lison D, Martens JA, et al. 2012. Cytokine production by co-cultures exposed to monodisperse amorphous silica nanoparticles: the role of size and surface area. Toxicol Lett 211(2):98–104.
  • Nemmar A, Hoet PH, Vanquickenborne B, Dinsdale D, Thomeer M, Hoylaerts MF, et al. 2002. Passage of inhaled particles into the blood circulation in humans. Circulation 105(4):411–414.
  • Netea MG, Nold-Petry CA, Nold MF, Joosten LA, Opitz B, van der Meer JH, et al. 2009. Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 113(10):2324–2335.
  • Neun BW, Dobrovolskaia MA. 2011. Detection and quantitative evaluation of endotoxin contamination in nanoparticle formulations by LAL-based assays. Methods Mol Biol 697:121–130.
  • North RA. 2002. Molecular physiology of P2X receptors. Physiol Rev 82(4):1013–1067.
  • Oberdorster G, Oberdorster E, Oberdorster J. 2005. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113(7):823–839.
  • Palomaki J, Valimaki E, Sund J, Vippola M, Clausen PA, Jensen KA, et al. 2011. Long, needle-like carbon nanotubes and asbestos activate the NLRP3 inflammasome through a similar mechanism. ACS Nano 5(9):6861–6870.
  • Pumera M, Miyahara Y. 2009. What amount of metallic impurities in carbon nanotubes is small enough not to dominate their redox properties? Nanoscale 1(2):260–265.
  • Renwick LC, Brown D, Clouter A, Donaldson K. 2004. Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types. Occup Environ Med 61(5): 442–447.
  • Rothen-Rutishauser B, Blank F, Muhlfeld C, Gehr P. 2008. In vitro models of the human epithelial airway barrier to study the toxic potential of particulate matter. Expert Opin Drug Metab Toxicol 4(8):1075–1089.
  • Rothen-Rutishauser BM, Kiama SG, Gehr P. 2005. A three-dimensional cellular model of the human respiratory tract to study the interaction with particles. Am J Respir Cell Mol Biol 32(4):281–289.
  • Roursgaard M, Jensen KA, Poulsen SS, Jensen NE, Poulsen LK, Hammer M, et al. 2011. Acute and subchronic airway inflammation after intratracheal instillation of quartz and titanium dioxide agglomerates in mice. Sci World J 11:801–825.
  • Schroder K, Tschopp J. 2010. The inflammasomes. Cell 140(6):821–832.
  • Schwende H, Fitzke E, Ambs P, Dieter P. 1996. Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3. J Leukoc Biol 59(4):555–561.
  • Stalmans P, Van Aken EH, Melles G, Veckeneer M, Feron EJ, Stalmans I. 2003. Trypan blue not toxic for retinal pigment epithelium in vitro. Am J Ophthalmol 135(2):234–236.
  • Tao F, Kobzik L. 2002. Lung macrophage-epithelial cell interactions amplify particle-mediated cytokine release. Am J Respir Cell Mol Biol 26(4):499–505.
  • Tetley TD. 2007. Health effects of nanomaterials. Biochem Soc Trans 35(Pt 3):527–531.
  • Val S, Hussain S, Boland S, Hamel R, Baeza-Squiban A, Marano F. 2009. Carbon black and titanium dioxide nanoparticles induce pro-inflammatory responses in bronchial epithelial cells: need for multiparametric evaluation due to adsorption artifacts. Inhal Toxicol 21(Suppl 1):115–122.
  • Wang CM, Chang YY, Sun SH. 2003. Activation of P2X7 purinoceptor-stimulated TGF-beta 1 mRNA expression involves PKC/MAPK signalling pathway in a rat brain-derived type-2 astrocyte cell line, RBA-2. Cell Signal 15(12):1129–1137.
  • Wottrich R, Diabate S, Krug HF. 2004. Biological effects of ultrafine model particles in human macrophages and epithelial cells in mono- and co-culture. Int J Hyg Environ Health 207(4):353–361.
  • Yazdi AS, Guarda G, Riteau N, Drexler SK, Tardivel A, Couillin I, et al. 2010. Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1alpha and IL-1beta. Proc Natl Acad Sci USA 107(45): 19449–19454.
  • Zucker RM, Massaro EJ, Sanders KM, Degn LL, Boyes WK. 2010. Detection of TiO2 nanoparticles in cells by flow cytometry. Cytometry A 77(7):677–685.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.